1. OMERACT III. Outcome measures in arthritis clinical trials. Cairns, Australia, April 16-19, 1997. Proceedings.;J Rheumatol,1997
2. Responsiveness of endpoints in osteoporosis clinical trials - an update.;Cranney;J Rheumatol,1999
3. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.;Farrar;J Natl Cancer Inst,1998
4. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.;Goldsmith;J Rheumatol,1993
5. Does it matter whom and how you ask? Inter- and intra-rater agreement in the Ontario Health Survey.;Grootendorst;J Clin Epidemiol,1997